Who invested in Congruence Therapeutics?
Congruence Therapeutics's investors include OrbiMed, BDC Capital, Dimension, Lumira Ventures and GO Capital Fund, and 5 more on record. OrbiMed led its latest round.

Canada · Funded startup
Funding summaryUpdated 26 Oct 2026
$72Mraised across 2 rounds since 2025, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by Lumira Ventures
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Congruence Therapeutics's investors include OrbiMed, BDC Capital, Dimension, Lumira Ventures and GO Capital Fund, and 5 more on record. OrbiMed led its latest round.
Congruence Therapeutics has raised $72M across 2 rounds since 2025.
Congruence Therapeutics's most recent round was an Undisclosed round of $40M in Mar 2026, led by OrbiMed.
Its most recent round, $40M in Mar 2026, is also its largest on record.
Congruence Therapeutics's first round on record, in Sept 2025, was backed by BDC Capital and OrbiMed.
Congruence Therapeutics's latest named round is an Undisclosed round, in Mar 2026.
Congruence Therapeutics is based in Canada.
OrbiMed led the Undisclosed round in 2026.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.